Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)

Overview

Constipation • Intestinal transit • Reduction of gastrointestinal discomfort • Leaky gut • Strengthening of natural defences and natural immunity • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production

Scientific reference(s)

Del Piano M. et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools. A double blind, randomized, placebo-controlled study. J Clin Gastroenterol, 2010; 44(8):S30-34.

Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly. CIBUS, 2005; 1(1):23-30.

Dimidi E. et al. The effect of probiotics on functional constipation in adults: a systematic review and metanalysis of randomized controlled trials. Am J Clin Nutr 2014;100:1075–84.

Del Piano M. et al. Comparison of the Kinetics of Intestinal Colonization by Associating 5 Probiotic Bacteria Assumed Either in Microencapsulated or in a Traditional, Uncoated Form. J Clin Gastroenterol 2012;46:S85-S92.

Mogna L. et al. Micronized Cells of the Probiotic Strain Bifidobacterium lactis BS01 Activate Monocyte Polarization: A New Approach. J Clin Gastroenterol. 2018;52:S57-S61.

Internal in vitro data available upon request on above-mentioned functions and strains at Probiotical.

Additional info

Therapeutical area(s)

Immune system · Gastrointestinal tract · Healthy ageing

Functionality

Immune stimulation · Antioxidant · Constipation · Gut permeability

Age/Gender

Adults

Search strain on Pubmed